Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2007;9(5):R104.
doi: 10.1186/ar2307.

Glucosamine affects intracellular signalling through inhibition of mitogen-activated protein kinase phosphorylation in human chondrocytes

Affiliations
Comparative Study

Glucosamine affects intracellular signalling through inhibition of mitogen-activated protein kinase phosphorylation in human chondrocytes

Anna Scotto d'Abusco et al. Arthritis Res Ther. 2007.

Abstract

The aim of this study was to determine the effects of glucosamine on matrix metalloprotease (MMP) production, on mitogen-activated protein kinase (MAPK) phosphorylation, and on activator protein (AP)-1 transcription factor activation in human chondrocytes. The human immortalized cell line lbpva55 and healthy human chondrocytes (obtained from healthy donors) were subjected to challenge with 10 ng/ml IL-1beta after pretreatment with 2.5 or 10 mmol/l glucosamine. MMP mRNA expression levels were evaluated using quantitative real-time PCR, and MMP protein production levels were evaluated in the culture supernatant using ELISA. MAPK phosphorylation was evaluated using Western blotting. AP-1 transcription factor activation was evaluated by measuring AP-1 DNA-binding activity. After IL-1beta stimulation, levels of MMP-1, MMP-3 and MMP-13 production were markedly increased. Treatment with 2.5 and 10 mmol/l glucosamine reduced expression of these metalloproteases. MMP expression is regulated by transcription factors such as the AP-1 complex, which is activated by phosphorylated MAPKs. IL-1beta stimulated phosphorylation of c-jun amino-terminal kinase, p38 MAPK and extracellular signal-regulated kinase-1/2. Glucosamine inhibited c-jun amino-terminal kinase and p38 phosphorylation, and consequently c-jun binding activity. These findings demonstrate, for the first time, that glucosamine inhibits IL-1beta-stimulated MMP production in human chondrocytes by affecting MAPK phosphorylation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effect of glucosamine on MMP-1 and MMP-13 expression in lbpva55 cells stimulated with 10 ng/ml IL-1β. Cells were pretreated for 2 hours with 2.5 or 10 mmol/l glucosamine (G2.5 and G10, respectively), and then stimulated with IL-1β for 22 hours. mRNA was extracted and analyzed by quantitative real-time PCR, and cell supernatant was analyzed by ELISA. Shown are (a) matrix metalloprotease (MMP)-1 and (b) MMP-13 mRNA levels, and (c) MMP-1 and (d) MMP-13 protein amounts. Quantitative real-time PCR results are expressed in relative arbitrary units (AU), and ELISA results are expressed in ng/ml or pg/ml. Results are expressed as mean ± standard error, obtained in three different experiments. *P ≤ 0.05. CTL, control.
Figure 2
Figure 2
Effect of glucosamine on MMP-3 expression in lbpva55 cell line stimulated with 10 ng/ml IL-1β. Cells were pretreated for 2 hours with 2.5 or 10 mmol/l glucosamine (G2.5 and G10, respectively), and then stimulated with IL-1β for 22 hours. mRNA was extracted and analyzed by quantitative real-time PCR, and cell supernatant was analyzed by ELISA. Shown are (a) matrix metalloprotease (MMP)-3 mRNA and (b) MMP-3 protein levels. Quantitative real-time PCR results are expressed in relative arbitrary units (AU) and ELISA results are expressed in ng/ml. Results are expressed as mean ± standard error, obtained in three different experiments. *P ≤ 0.05. CTL, control.
Figure 3
Figure 3
Effect of glucosamine on MMP-1 and MMP-13 expression in HPCs stimulated with 10 ng/ml IL-1β. Cells were pretreated for 2 hours with 2.5 and 10 mmol/l glucosamine (G2.5 and G10, respectively), and then stimulated with IL-1β for 22 hours. mRNA was extracted and analyzed by quantitative real-time PCR, and cell supernatant was analyzed by ELISA. Shown are (a) matrix metalloprotease (MMP)-1 and (b) MMP-13 mRNA levels, and (c) MMP-1 and (d) MMP-13 protein amounts. Quantitative real-time PCR results are expressed in relative arbitrary units (AU) and ELISA results are expressed in ng/ml or pg/ml. Results are expressed as mean ± standard error, obtained in six different experiments. *P ≤ 0.05. CTL, control; HPC, human primary chondrocyte.
Figure 4
Figure 4
Effect of glucosamine on MMP-3 expression in HCPs stimulated with 10 ng/ml IL-1β. Cells were pretreated for 2 hours with 2.5 or 10 mmol/l glucosamine (G2.5 and G10, respectively), and then stimulated with IL-1β for 22 hours. mRNA was extracted and analyzed by quantitative real-time PCR, and cell supernatant was analyzed by ELISA. Shown are (a) matrix metalloprotease (MMP)-3 mRNA level and (b) MMP-3 protein level. Quantitative real-time PCR results are expressed in relative arbitrary units (AU) and ELISA results are expressed in ng/ml. Results are expressed as mean ± standard error, obtained in six different experiments. *P ≤ 0.05. CTL, control; HPC, human primary chondrocyte.
Figure 5
Figure 5
Effect of glucosamine MAPK phosphorylation in lbpva55 cells stimulated with 10 ng/ml IL-1β. Cells were pretreated for 2 hours with 2.5 or 10 mmol/l glocosamine (G2.5 and G10, respectively), and then stimulated with IL-1β for 15 minutes. Whole cell extract was prepared as described in Materials and methods. Proteins were resolved on SDS-PAGE, electrotransferred, and immunoblotted. Antibodies to (a) phosphorylated (p)-c-jun amino-terminal kinase (JNK) and total JNK, (b) p-p38 and total p38, and (c) p-extracellular signal-regulated kinase (ERK)1/2 and total ERK1/2 were used to visualize mitogen-activated protein kinase (MAPK) phosphorylation. Representative data from three independent experiments are shown. CTL, control.
Figure 6
Figure 6
Effect of glucosamine MAPK phosphorylation in HPCs stimulated with 10 ng/ml IL-1β. Cells were pretreated for 2 hours with 2.5 or 10 mmol/l glucosamine (G2.5 and G10, respectively), and then stimulated with IL-1β for 15 minutes. Whole cell extract was prepared as described in Materials and methods. Proteins were resolved on SDS-PAGE, electrotransferred and immunoblotted. Antibodies to (a) phosphorylated (p)-c-jun amino-terminal kinase (JNK) and total JNK, (b) p-p38 and total p38, and (c) p-extracellular signal-regulated kinase (ERK)1/2 and total ERK1/2 were used to visualize mitogen-activated protein kinase (MAPK) phosphorylation. Representative data from six independent experiments are shown. CTL, control; HPC, human primary chondrocyte.
Figure 7
Figure 7
Effect of glucosamine on c-jun DNA-binding activity in HPCs stimulated with 10 ng/ml IL-1β. Cells were pretreated with 2.5 and 10 mmol/l glucosamine (G2.5 and G10, respectively) for 2 hours and then stimulated with IL-1β for 15 minutes. Nuclear extract was prepared as described in Materials and methods. Results are expressed as optical density (OD) measured at 450 nm and represent the mean ± standard error of data obtained in six different experiments. *P ≤ 0.05. CTL, control; HPC, human primary chondrocyte.

Similar articles

Cited by

References

    1. Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O, Giacovelli G, Henrotin Y, Dacre JE, Gosset C. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet. 2001;357:251–256. doi: 10.1016/S0140-6736(00)03610-2. - DOI - PubMed
    1. Pavelka K, Gatterova J, Olejarova M, Machacek S, Giacovelli G, Rovati LC. Glucosamine sulphate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med. 2002;162:2113–2123. doi: 10.1001/archinte.162.18.2113. - DOI - PubMed
    1. Bruyere O, Honore A, Ethgen O, Rovati LC, Giacovelli G, Henrotin YE, Seidel L, Reginster JY. Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate. Osteoarthritis Cartilage. 2003;11:1–5. doi: 10.1053/joca.2002.0848. - DOI - PubMed
    1. Towheed TE. Current status of glucosamine therapy in osteoarthritis. Arthritis Rheum. 2003;49:601–604. doi: 10.1002/art.11183. - DOI - PubMed
    1. Muller-Fassbender H, Bach GL, Haase W, Rovati LC, Setnikar I. Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee. Osteoarthritis Cartilage. 1994;2:61–69. doi: 10.1016/S1063-4584(05)80007-X. - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources